Value-Based Health Care for Prostate Cancer Centers by Implementing Specific Key Performance Indicators Using a...

Area of Science:

• Oncology
• Healthcare Management
• Value-Based Medicine

Background:

• Prostate cancer (PC) is a leading cancer globally, necessitating improved diagnostics and treatments.
• Current challenges include a shortage of cost-effective diagnostics and universally safe treatment options.
• Value-based medicine requires instruments for consistent measurability, such as the Balanced Scorecard (BSC).

Purpose of the Study:

• To propose the first Balanced Scorecard (BSC) specifically designed for prostate cancer (PC) treatment.
• To identify Key Performance Indicators (KPIs) for assessing PC care performance across multiple dimensions.

Main Methods:

• A systematic literature search adhering to PRISMA guidelines was performed.
• Key Performance Indicators (KPIs) for PC care were identified from 44 selected reports.
• The study developed a PC-specific BSC incorporating established and novel perspectives.

Main Results:

• A PC-specific BSC was defined with four classic perspectives and a new PC-Specific Disease and Outcome perspective.
• Patient-related parameters from the German Cancer Society and ICHOM were integrated.
• The Learning and Development perspective includes KPIs for resident training and radical prostatectomy procedure metrics.

Conclusions:

• The developed BSC offers a comprehensive framework for Integrated Practice Units in PC care.
• It systematically collects and provides data for value creation, aligning with the Full Cycle of Care model.
• The BSC incorporates KPIs for structured training and metrics proven to improve PC patient outcomes.